Merck (MRK) Other financing activities (2009 - 2026)

Merck (MRK) has 18 years of Other financing activities data on file, last reported at -$80.0 million in Q1 2026.

• Other financing activities for Q1 2026 came in at -$80.0 million, down 33.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$151.0 million (up 57.34% YoY), and the FY2025 annual result was -$131.0 million, up 64.78% from the prior year.
• Other financing activities declined to -$80.0 million in Q1 2026 per MRK's latest filing, from $121.0 million in the prior quarter.
• Over five years, Other financing activities peaked at $121.0 million in Q4 2025 and troughed at -$234.0 million in Q2 2023.
• A 5-year average of -$67.7 million and a median of -$68.0 million in 2022 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2024 and 2025: Other financing activities sank 1300.0% in 2024, then soared 388.1% in 2025.
• A 5-year view of Other financing activities shows it stood at -$68.0 million in 2022, then surged by 95.59% to -$3.0 million in 2023, then slumped by 1300.0% to -$42.0 million in 2024, then jumped by 388.1% to $121.0 million in 2025, then plunged by 166.12% to -$80.0 million in 2026.
• Business Quant data shows MRK's Other financing activities at -$80.0 million in Q1 2026, $121.0 million in Q4 2025, and $2.0 million in Q3 2025.